SAGE
Price
$9.20
Change
+$0.12 (+1.32%)
Updated
Jul 3 closing price
Capitalization
576.12M
31 days until earnings call
TIL
Price
$27.50
Change
+$3.69 (+15.50%)
Updated
Jul 3 closing price
Capitalization
180.4M
Interact to see
Advertisement

SAGE vs TIL

Header iconSAGE vs TIL Comparison
Open Charts SAGE vs TILBanner chart's image
Sage Therapeutics
Price$9.20
Change+$0.12 (+1.32%)
Volume$3.01M
Capitalization576.12M
Instil Bio
Price$27.50
Change+$3.69 (+15.50%)
Volume$596.59K
Capitalization180.4M
SAGE vs TIL Comparison Chart in %
Loading...
SAGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TIL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SAGE vs. TIL commentary
Jul 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SAGE is a StrongBuy and TIL is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 05, 2025
Stock price -- (SAGE: $9.20 vs. TIL: $27.50)
Brand notoriety: SAGE and TIL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: SAGE: 170% vs. TIL: 172%
Market capitalization -- SAGE: $576.12M vs. TIL: $180.4M
SAGE [@Biotechnology] is valued at $576.12M. TIL’s [@Biotechnology] market capitalization is $180.4M. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SAGE’s FA Score shows that 1 FA rating(s) are green whileTIL’s FA Score has 1 green FA rating(s).

  • SAGE’s FA Score: 1 green, 4 red.
  • TIL’s FA Score: 1 green, 4 red.
According to our system of comparison, both SAGE and TIL are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SAGE’s TA Score shows that 7 TA indicator(s) are bullish while TIL’s TA Score has 5 bullish TA indicator(s).

  • SAGE’s TA Score: 7 bullish, 3 bearish.
  • TIL’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, SAGE is a better buy in the short-term than TIL.

Price Growth

SAGE (@Biotechnology) experienced а -0.86% price change this week, while TIL (@Biotechnology) price change was +24.04% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.93%. For the same industry, the average monthly price growth was +17.38%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

SAGE is expected to report earnings on Aug 05, 2025.

TIL is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Biotechnology (+6.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SAGE($576M) has a higher market cap than TIL($180M). SAGE YTD gains are higher at: 69.429 vs. TIL (44.054). TIL has higher annual earnings (EBITDA): -67.77M vs. SAGE (-358.98M). SAGE has more cash in the bank: 424M vs. TIL (104M). SAGE has less debt than TIL: SAGE (11.9M) vs TIL (86.7M). SAGE has higher revenues than TIL: SAGE (47.4M) vs TIL (0).
SAGETILSAGE / TIL
Capitalization576M180M320%
EBITDA-358.98M-67.77M530%
Gain YTD69.42944.054158%
P/E RatioN/AN/A-
Revenue47.4M0-
Total Cash424M104M408%
Total Debt11.9M86.7M14%
FUNDAMENTALS RATINGS
SAGE vs TIL: Fundamental Ratings
SAGE
TIL
OUTLOOK RATING
1..100
4776
VALUATION
overvalued / fair valued / undervalued
1..100
33
Fair valued
21
Undervalued
PROFIT vs RISK RATING
1..100
10093
SMR RATING
1..100
9796
PRICE GROWTH RATING
1..100
3837
P/E GROWTH RATING
1..100
98100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TIL's Valuation (21) in the Precious Metals industry is in the same range as SAGE (33) in the Pharmaceuticals Other industry. This means that TIL’s stock grew similarly to SAGE’s over the last 12 months.

TIL's Profit vs Risk Rating (93) in the Precious Metals industry is in the same range as SAGE (100) in the Pharmaceuticals Other industry. This means that TIL’s stock grew similarly to SAGE’s over the last 12 months.

TIL's SMR Rating (96) in the Precious Metals industry is in the same range as SAGE (97) in the Pharmaceuticals Other industry. This means that TIL’s stock grew similarly to SAGE’s over the last 12 months.

TIL's Price Growth Rating (37) in the Precious Metals industry is in the same range as SAGE (38) in the Pharmaceuticals Other industry. This means that TIL’s stock grew similarly to SAGE’s over the last 12 months.

SAGE's P/E Growth Rating (98) in the Pharmaceuticals Other industry is in the same range as TIL (100) in the Precious Metals industry. This means that SAGE’s stock grew similarly to TIL’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
SAGETIL
RSI
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
87%
Momentum
ODDS (%)
Bullish Trend 3 days ago
76%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bullish Trend 3 days ago
78%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
79%
Bullish Trend 3 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
75%
Bearish Trend 3 days ago
88%
Advances
ODDS (%)
Bullish Trend 10 days ago
77%
Bullish Trend 3 days ago
84%
Declines
ODDS (%)
Bearish Trend 5 days ago
80%
Bearish Trend 10 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
88%
Aroon
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
68%
View a ticker or compare two or three
Interact to see
Advertisement
SAGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TIL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
QASGX26.710.30
+1.14%
Federated Hermes MDT Small Cap Growth A
TGVFX53.260.56
+1.06%
Touchstone Dynamic Large Cap Growth A
CZMVX16.540.08
+0.49%
Multi-Manager Value Strategies Inst
JPVRX17.710.04
+0.23%
JPMorgan Developed International ValueR5
RYVCX151.73-0.80
-0.52%
Rydex Energy Services C

TIL and

Correlation & Price change

A.I.dvisor indicates that over the last year, TIL has been loosely correlated with SMMT. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if TIL jumps, then SMMT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TIL
1D Price
Change %
TIL100%
+15.50%
SMMT - TIL
52%
Loosely correlated
+8.53%
BNTX - TIL
50%
Loosely correlated
+1.61%
XNCR - TIL
39%
Loosely correlated
+1.45%
DNLI - TIL
35%
Loosely correlated
-1.41%
IMNM - TIL
35%
Loosely correlated
+2.43%
More